Navigating the Antibody Drug Conjugates Landscape

In this report, we analyze Antibody-drug conjugates (ADCs), a class of highly targeted biopharmaceutical drugs designed to treat diseases, primarily cancer, by combining the specificity of monoclonal antibodies with the potency of cytotoxic agents.